SG10201914102UA - Stem cells for wound healing - Google Patents

Stem cells for wound healing

Info

Publication number
SG10201914102UA
SG10201914102UA SG10201914102UA SG10201914102UA SG10201914102UA SG 10201914102U A SG10201914102U A SG 10201914102UA SG 10201914102U A SG10201914102U A SG 10201914102UA SG 10201914102U A SG10201914102U A SG 10201914102UA SG 10201914102U A SG10201914102U A SG 10201914102UA
Authority
SG
Singapore
Prior art keywords
stem cells
wound healing
healing
wound
stem
Prior art date
Application number
SG10201914102UA
Other languages
English (en)
Inventor
Aernout Luttun
Robert Deans
Original Assignee
Abt Holding Co
Univ Leuven Kath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abt Holding Co, Univ Leuven Kath filed Critical Abt Holding Co
Publication of SG10201914102UA publication Critical patent/SG10201914102UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/12—Animals modified by administration of exogenous cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG10201914102UA 2016-01-21 2016-02-12 Stem cells for wound healing SG10201914102UA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662281334P 2016-01-21 2016-01-21

Publications (1)

Publication Number Publication Date
SG10201914102UA true SG10201914102UA (en) 2020-03-30

Family

ID=59360064

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201914102UA SG10201914102UA (en) 2016-01-21 2016-02-12 Stem cells for wound healing
SG11201806245TA SG11201806245TA (en) 2016-01-21 2016-02-12 Stem cells for wound healing

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201806245TA SG11201806245TA (en) 2016-01-21 2016-02-12 Stem cells for wound healing

Country Status (11)

Country Link
US (2) US10967006B2 (ja)
EP (1) EP3405566B1 (ja)
JP (3) JP6918003B2 (ja)
KR (1) KR20180102661A (ja)
CN (1) CN108884437A (ja)
AU (2) AU2016387339B2 (ja)
CA (1) CA3012330A1 (ja)
HK (1) HK1256413A1 (ja)
NZ (1) NZ745530A (ja)
SG (2) SG10201914102UA (ja)
WO (1) WO2017127123A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2568991B3 (en) 2010-05-12 2018-11-28 ABT Holding Company Modulation of splenocytes in cell therapy
CN105338989B (zh) 2013-04-12 2022-04-08 赛维里奥·拉弗朗切西卡 改进用于移植的器官
NZ745530A (en) * 2016-01-21 2023-03-31 Abt Holding Co Stem cells for wound healing
WO2019059741A1 (ko) * 2017-09-25 2019-03-28 사회복지법인 삼성생명공익재단 뇌척수액을 포함하는 줄기세포 투여 제형 및 그의 제조방법

Family Cites Families (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US7037721B1 (en) 1990-01-29 2006-05-02 Hy-Gene Biomedical, Inc. Protein-free defined media for the growth of normal human keratinocytes
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
CA2123094C (en) 1991-11-06 1999-08-10 Paulo N. Correa Cell culture medium
WO1994000484A1 (en) 1992-06-22 1994-01-06 Young Henry E Scar inhibitory factor and use thereof
US5766951A (en) 1992-11-12 1998-06-16 Quality Biological, Inc. Serum-free medium supporting growth and proliferation of normal bone marrow cells
US6037174A (en) 1993-08-23 2000-03-14 Nexell Therapeutics, Inc. Preparation of serum-free suspensions of human hematopoietic cells or precursor cells
US5409813A (en) 1993-09-30 1995-04-25 Systemix, Inc. Method for mammalian cell separation from a mixture of cell populations
GB9502022D0 (en) 1995-02-02 1995-03-22 Abuljadayel Ilham M S A method for preparing lymphohaematopoietic progenitor cells
US5906934A (en) 1995-03-14 1999-05-25 Morphogen Pharmaceuticals, Inc. Mesenchymal stem cells for cartilage repair
US6653134B2 (en) 1995-03-28 2003-11-25 Cp Hahnemann University Isolated stromal cells for use in the treatment of diseases of the central nervous system
US5908782A (en) 1995-06-05 1999-06-01 Osiris Therapeutics, Inc. Chemically defined medium for human mesenchymal stem cells
US5945337A (en) 1996-10-18 1999-08-31 Quality Biological, Inc. Method for culturing CD34+ cells in a serum-free medium
AU7984498A (en) 1997-06-25 1999-01-04 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Serum-free cell growth medium
US6077987A (en) 1997-09-04 2000-06-20 North Shore-Long Island Jewish Research Institute Genetic engineering of cells to enhance healing and tissue regeneration
RU2272839C2 (ru) 1998-11-09 2006-03-27 Консорцио Пер Ла Джестионе Дель Чентро Ди Биотекнолоджие Аванцате Бессывороточная среда для культуры клеток, используемых для реконструкции костных и хрящевых сегментов (варианты)
US6777231B1 (en) 1999-03-10 2004-08-17 The Regents Of The University Of California Adipose-derived stem cells and lattices
US20050169896A1 (en) 1999-05-14 2005-08-04 Henry Ford Health System Bone marrow transplantation for treatment of stroke
WO2005056026A1 (en) 2003-12-04 2005-06-23 Regents Of The University Of Minnesota Compositions and methods for the treatment of lysosomal storage disorders
US7927587B2 (en) 1999-08-05 2011-04-19 Regents Of The University Of Minnesota MAPC administration for the treatment of lysosomal storage disorders
DK1226233T3 (da) 1999-08-05 2011-10-03 Abt Holding Co Multipotente voksne stamceller og fremgangsmåder til isolering heraf
US8075881B2 (en) 1999-08-05 2011-12-13 Regents Of The University Of Minnesota Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure
US10638734B2 (en) 2004-01-05 2020-05-05 Abt Holding Company Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
US8147824B2 (en) 1999-08-05 2012-04-03 Athersys, Inc. Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
US8252280B1 (en) 1999-08-05 2012-08-28 Regents Of The University Of Minnesota MAPC generation of muscle
US8609412B2 (en) 1999-08-05 2013-12-17 Regents Of The University Of Minnesota Mapc generation of lung tissue
US7015037B1 (en) 1999-08-05 2006-03-21 Regents Of The University Of Minnesota Multiponent adult stem cells and methods for isolation
DE60041821D1 (de) 1999-09-24 2009-04-30 Cybios Llc Pluripotent embryonale stammzellen-ähnliche zellen, zusammensetzungen und ihre vervendungen
US20030161817A1 (en) 2001-03-28 2003-08-28 Young Henry E. Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
EP1218489B1 (en) 1999-09-24 2009-03-18 Cybios LLC Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
US20010046489A1 (en) 1999-12-06 2001-11-29 Habener Joel E. Stem cells of the islets of langerhans and their use in treating diabetes mellitus
PT1261694E (pt) 2000-02-26 2008-04-03 Artecel Inc Células estaminais pluripotentes produzidas a partir de células estromais derivadas de tecido adiposo e suas utilizações.
AU2001284695A1 (en) 2000-07-31 2002-02-13 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
US7560280B2 (en) 2000-11-03 2009-07-14 Kourion Therapeutics Gmbh Human cord blood derived unrestricted somatic stem cells (USSC)
KR100915482B1 (ko) 2000-12-06 2009-09-03 하리리 로버트 제이 태반 줄기 세포의 회수 방법
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
JP2004529621A (ja) 2001-02-14 2004-09-30 ティー ファークト，レオ 多能性成体幹細胞、その起源、それを得る方法および維持する方法、それを分化させる方法、その使用法、ならびにそれ由来の細胞
EP2316919B1 (en) 2001-02-14 2015-10-07 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
US7056738B2 (en) 2001-03-23 2006-06-06 Tulane University Early stage multipotential stem cells in colonies of bone marrow stromal cells
KR100449141B1 (ko) 2001-04-19 2004-09-21 (주)라이프코드 간엽 간세포를 신경세포로 분화시키는 방법
CA2444959C (en) 2001-04-24 2014-07-08 Dolores Baksh Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom
US20030003090A1 (en) 2001-05-31 2003-01-02 Prockop Darwin J. Directed in vitro differentiation of marrow stromal cells into neural cell progenitors
US9969980B2 (en) 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
JP2005515777A (ja) 2002-01-25 2005-06-02 ジェンザイム・コーポレーション 軟骨細胞のための無血清培地およびその使用法
AU2003298016A1 (en) 2002-11-27 2004-06-23 Regents Of The University Of Minnesota Homologous recombination in multipotent adult progenitor cells
CA2784829C (en) 2003-04-01 2015-10-06 United States Of America Department Of Veteran's Affairs Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction
US20040235165A1 (en) 2003-05-19 2004-11-25 Darwin Prockop In vitro differentiation of adult stem cells
WO2005003317A2 (en) 2003-07-01 2005-01-13 Regents Of The University Of Minnesota Engineered blood vessels
WO2005003320A2 (en) 2003-07-02 2005-01-13 Regents Of The University Of Minnesota Neuronal differentiation of stem cells
AU2004269409A1 (en) 2003-08-29 2005-03-10 Regents Of The University Of Minnesota Kidney derived stem cells and methods for their isolation, differentiation and use
US7794706B2 (en) 2003-10-14 2010-09-14 Medivas, Llc Bioactive wound dressings and implantable devices and methods of use
EP1725656B1 (en) 2004-03-05 2013-10-02 John E. Davies Serum-free suspension culture system for mesenchymal progenitor cells
EP2298862B1 (en) 2004-03-22 2017-08-30 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor
CA2564652C (en) 2004-04-21 2020-07-14 Regents Of The University Of Minnesota Mapc generation of lung tissue
WO2006047743A2 (en) 2004-10-26 2006-05-04 Regents Of The University Of Minnesota Swine multipotent adult progenitor cells
KR100593397B1 (ko) 2004-10-27 2006-06-28 한국원자력연구소 중배엽 줄기세포 및/또는 ｐ 물질을 함유하는 상처 치유또는 상처 치유 촉진제, 또는 세포 치료제
EP2428563A1 (en) 2005-02-10 2012-03-14 Regents Of The University Of Minnesota Vascular/lymphatic endothelial cells
US20080317740A1 (en) 2005-05-05 2008-12-25 Bruce Blazar Use of Nk Cell Inhibition to Facilitate Persistence of Engrafted Mhc-I-Negative Cells
WO2006121454A2 (en) * 2005-05-05 2006-11-16 Regents Of The University Of Minnesota Use of mapc or progeny therefrom to populate lymphohematopoietic tissues
US20080194024A1 (en) 2005-07-29 2008-08-14 Mays Robert W Culture of Non-Embryonic Cells at High Cell Density
US20080194021A1 (en) 2005-07-29 2008-08-14 Mays Robert W Use of a Gsk-3 Inhibitor to Maintain Potency of Culture Cells
NZ567082A (en) 2005-10-14 2012-08-31 Univ Minnesota Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype
US20220110982A1 (en) 2005-11-09 2022-04-14 Abt Holding Company Mapc treatment of brain injuries and diseases
US10117900B2 (en) 2005-11-09 2018-11-06 Athersys, Inc. MAPC treatment of brain injuries and diseases
US11000546B2 (en) 2005-11-09 2021-05-11 Athersys, Inc. Immunomodulatory properties of MAPCs and uses thereof
US8871198B2 (en) 2006-03-29 2014-10-28 Stemnion, Inc. Methods related to wound healing
CN101410125A (zh) 2006-01-23 2009-04-15 阿特西斯公司 脑损伤和疾病的mapc治疗
WO2008063675A2 (en) 2006-11-24 2008-05-29 Regents Of The University Of Minnesota Endodermal progenitor cells
WO2008154368A2 (en) * 2007-06-08 2008-12-18 University Of Virginia Patent Foundation Topical poloxamer formulations for enhancing microvascular flow: compositions and uses thereof
AU2009205886B2 (en) 2008-01-18 2015-08-27 Katholieke Universiteit Leuven Stem cell aggregates and methods for making and using
NZ587598A (en) 2008-02-29 2012-10-26 Univ New York State Res Found Methods of increasing proliferation of a cell by administering a low magnitude, high frequency mechanical signal
EP2282746B8 (en) 2008-03-27 2015-12-09 Caladrius Biosciences, Inc. Compositions and methods using stem cells in cutaneous wound healing
CA2723765A1 (en) * 2008-05-08 2009-11-12 Coretherapix Slu Multipotent adult stem cell population
WO2009155334A1 (en) 2008-06-20 2009-12-23 Escape Therapeutics, Inc. Differentiation of mesenchymal stem cells into fibroblasts, compositions comprising mesenchymal stem cell-derived fibroblasts, and methods of using the same
SG193847A1 (en) 2008-09-04 2013-10-30 Abt Holding Co Use of stem cells to prevent neuronal dieback
US9057051B2 (en) 2008-10-31 2015-06-16 Katholieke Universiteit Leuven Optimized methods for differentiation of cells into cells with hepatocyte progenitor phenotypes, cells produced by the methods, and methods of using the cells
AU2010276201B2 (en) 2009-07-21 2013-10-17 Abt Holding Company Use of stem cells to reduce leukocyte extravasation
DK2456860T3 (en) 2009-07-21 2019-01-07 Abt Holding Co USE OF STEM CELLS FOR REDUCING LEUKOCYTE EXTRAVASATION
JP2013510582A (ja) 2009-11-12 2013-03-28 ザ テキサス エーアンドエム ユニバーシティー システム 間葉幹細胞の球状集合体
US20130129686A1 (en) 2009-11-19 2013-05-23 Regents Of The University Reducing Inflammation Using Cell Therapy
US20150010610A1 (en) 2010-02-18 2015-01-08 Osiris Therapeutics, Inc. Immunocompatible amniotic membrane products
US20110206647A1 (en) 2010-02-25 2011-08-25 Abt Holding Company Modulation of Angiogenesis
WO2011106476A1 (en) 2010-02-25 2011-09-01 Abt Holding Company Modulation of microglia activation
AU2011220721B2 (en) 2010-02-25 2015-02-05 Abt Holding Company Modulation of macrophage activation
CN102198156A (zh) 2010-03-26 2011-09-28 傅毓秀 用于治疗皮肤创伤之医药组合物
WO2011143411A1 (en) 2010-05-12 2011-11-17 Abt Holding Company Modulation of splenocytes in cell therapy for traumatic brain injury
EP2568991B3 (en) 2010-05-12 2018-11-28 ABT Holding Company Modulation of splenocytes in cell therapy
WO2011158125A2 (en) 2010-06-17 2011-12-22 Katholieke Universiteit Leuven Methods for differentiating cells into hepatic stellate cells and hepatic sinusoidal endothelial cells, cells produced by the methods, and methods for using the cells
WO2012009581A2 (en) 2010-07-14 2012-01-19 University Of Southern California Pharmaceutical compositions comprising gingiva-derived mesenchymal stem cells and methods of treating inflammation, wound healing and contact hypersensitivity
IL207586A0 (en) 2010-08-12 2010-12-30 Omrix Biopharmaceuticals Ltd A fibrin based therapeutic preparation and use thereof
EP2609191B1 (en) 2010-08-24 2017-11-22 Regents Of The University Of Minnesota Non-static suspension culture of cell aggregates
EP2670842A2 (en) 2011-01-31 2013-12-11 Katholieke Universiteit Leuven KU Leuven Research & Development Methods for making cells with an extra-embryonic endodermal precursor phenotype
US20120308531A1 (en) 2011-06-06 2012-12-06 ReGenesys BVBA Expansion of Stem Cells in Hollow Fiber Bioreactors
CN105338989B (zh) 2013-04-12 2022-04-08 赛维里奥·拉弗朗切西卡 改进用于移植的器官
DK2992088T3 (da) 2013-04-30 2019-11-11 Univ Leuven Kath Celleterapi for myelodysplastiske syndromer
WO2014210037A2 (en) 2013-06-24 2014-12-31 University Of Southern California Composition of mesenchymal stem cells
WO2015017772A1 (en) * 2013-08-01 2015-02-05 Parcell Laboratories, Llc Stem cell-based preparations and methods for dermal and connective tissue reconstruction and rejuvenation
US20160175485A1 (en) 2013-08-27 2016-06-23 The Regents Of The University Of California Combination therapy to promote wound healing
US20160069903A1 (en) 2014-09-10 2016-03-10 Fundació Institute De Ciències Foròniques Method for detecting cells
EP3291822A1 (en) 2015-05-05 2018-03-14 Katholieke Universiteit Leuven Improved methods for pancreatic islet transplantation
CA3012009A1 (en) 2015-10-09 2017-04-13 Abt Holding Company Methods for enhancing proliferation of t regulatory cells
NZ745530A (en) * 2016-01-21 2023-03-31 Abt Holding Co Stem cells for wound healing
US20200246390A1 (en) 2019-02-01 2020-08-06 Abt Holding Company Multipotent adult projenitor cells for treatment of ich

Also Published As

Publication number Publication date
EP3405566B1 (en) 2023-10-18
US20220031756A1 (en) 2022-02-03
SG11201806245TA (en) 2018-08-30
CA3012330A1 (en) 2017-07-27
WO2017127123A1 (en) 2017-07-27
CN108884437A (zh) 2018-11-23
EP3405566A1 (en) 2018-11-28
HK1256413A1 (zh) 2019-09-20
JP2019506396A (ja) 2019-03-07
JP2022163207A (ja) 2022-10-25
AU2016387339B2 (en) 2022-11-17
KR20180102661A (ko) 2018-09-17
US20170209493A1 (en) 2017-07-27
JP6918003B2 (ja) 2021-08-11
US10967006B2 (en) 2021-04-06
NZ745530A (en) 2023-03-31
AU2022211794A1 (en) 2022-08-25
JP2020172536A (ja) 2020-10-22
EP3405566A4 (en) 2019-07-31
US11918609B2 (en) 2024-03-05
AU2016387339A1 (en) 2018-08-23

Similar Documents

Publication Publication Date Title
IL267226A (en) Evaporator
EP3518315A4 (en) WOUND CELL
EP3490622C0 (en) METHODS AND COMPOSITIONS FOR WOUND HEALING
PL2896395T3 (pl) Preparat do miejscowego leczenia ran
GB201712733D0 (en) Methods & cells
GB201518669D0 (en) Wound dressing
SG10202000644TA (en) Improved Stem Cell Composition
HK1245159A1 (zh) 脫細胞化組織
HK1256413A1 (zh) 用於傷口癒合的幹細胞
PL3288510T3 (pl) Opatrunek na rany
GB201701509D0 (en) Pluripotenet stem cells
GB201404944D0 (en) Wound dressing
ZA201707843B (en) Wound dressing
ZA201900891B (en) B-cell-mimetic cells
EP3374495A4 (en) IMPROVED METHODS OF FABRICATING FABRICS
SI3030232T1 (sl) Celjenje ran s pomočjo mobilizacije avtolognih matičnih celic
HK1258273A1 (zh) 用於傷口閉合的裝置
GB201805287D0 (en) Haematoietic stem cell treatment
GB201512582D0 (en) Wound treatment
PL3393415T3 (pl) Bandaż
GB2542107B (en) Winding former
PL3131572T3 (pl) Analog apc do zastosowania w zaleczaniu rany
PL3507300T3 (pl) Peptyd gojący ranę
SG10201403640XA (en) Stem cells
SG11202104087QA (en) Stem cell therapy